Cargando…
Association of serum beta hCG levels in women with palpable malignant breast lesions
This study aims to determine whether serum Beta hCG can be used as a tumour marker in Breast malignancies. The objective of this study is to evaluate the serum Beta hCG in various stages of breast carcinoma and to correlate its level with disease severity and prognosis. Cross sectional analytical st...
Autores principales: | Mohammed, Ashfaque, Ahmed, Talha, Bhat, Rahul R., Mallik, Esha, Arulprakasam, Aashika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425361/ https://www.ncbi.nlm.nih.gov/pubmed/37580469 http://dx.doi.org/10.1038/s41598-023-40056-1 |
Ejemplares similares
-
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Beta-hCG expression by bladder cancers.
por: Iles, R.
Publicado: (1992) -
Elevated serum beta-hCG due to a tumour of unknown origin.
por: Kenny, L., et al.
Publicado: (2004) -
Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
por: Christensen, T B, et al.
Publicado: (1999) -
Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
por: Mora, J., et al.
Publicado: (1996)